MWA
ELV icon

Marshall Wace Asia’s Elevance Health ELV Stock Holding History

Marshall Wace Asia’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,652
Closed -$5.93M – 144
2019
Q4 		$5.93M Buy
+19,652
New +$5.41M 0.15% 70
2019
Q1 		– Sell
-19,304
Closed -$5.07M – 107
2018
Q4 		$5.07M Buy
+19,304
New +$5.31M 0.19% 56
2018
Q3 		– Sell
-20,896
Closed -$4.97M – 99
2018
Q2 		$4.97M Buy
+20,896
New +$4.84M 0.16% 63

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace Asia's ELV Position: Q1 2020 in Review

Marshall Wace Asia sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 19,652 shares — an estimated $5.93M sold.

Marshall Wace Asia first reported a position in ELV in Q2 2018 and held it in 3 quarters. The position peaked at $5.93M in Q4 2019. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Marshall Wace Asia reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 19,652 Elevance Health shares in Q1 2020, an estimated $5.93M.
  • Marshall Wace Asia first reported a position in Elevance Health in Q2 2018 and held it in 3 quarters.
  • Marshall Wace Asia's Elevance Health position peaked at $5.93M in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Marshall Wace Asia's 13F filing for Q1 2020, filed 15 May 2020.